These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2031874)

  • 21. Interactions of propionate and carnitine metabolism in isolated rat hepatocytes.
    Brass EP; Beyerinck RA
    Metabolism; 1987 Aug; 36(8):781-7. PubMed ID: 3110541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propionate inhibition of succinate:CoA ligase (GDP) and the citric acid cycle in mitochondria.
    Stumpf DA; McAfee J; Parks JK; Eguren L
    Pediatr Res; 1980 Oct; 14(10):1127-31. PubMed ID: 6780967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat.
    Broderick TL; Driedzic W; Paulson DJ
    Mol Cell Biochem; 2000 Mar; 206(1-2):151-7. PubMed ID: 10839205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceleration of gluconeogenesis from propionate by Dl-carnitine in the rat kidney cortex.
    Weidemann MJ; Krebs HA
    Biochem J; 1969 Jan; 111(1):69-81. PubMed ID: 4887195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of L-carnitine on tissue levels of free fatty acid, acyl CoA, and acylcarnitine in ischemic heart.
    Suzuki Y; Kamikawa T; Kobayashi A; Yamazaki N
    Adv Myocardiol; 1983; 4():549-57. PubMed ID: 6856980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propionate mitochondrial toxicity in liver and skeletal muscle: acyl CoA levels.
    Matsuishi T; Stumpf DA; Seliem M; Eguren LA; Chrislip K
    Biochem Med Metab Biol; 1991 Apr; 45(2):244-53. PubMed ID: 1883630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the cardiostimulant action of propionyl-L-carnitine on chronically volume-overloaded rat hearts.
    el Alaoui-Talibi Z; Bouhaddioni N; Moravec J
    Cardiovasc Drugs Ther; 1993 Jun; 7(3):357-63. PubMed ID: 8364005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of propionyl-L-carnitine during ischemia and reperfusion.
    Shug A; Paulson D; Subramanian R; Regitz V
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():77-83. PubMed ID: 2031875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-L-carnitine.
    El Alaoui-Talibi Z; Guendouz A; Moravec M; Moravec J
    Am J Physiol; 1997 Apr; 272(4 Pt 2):H1615-24. PubMed ID: 9139943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion.
    Mister M; Noris M; Szymczuk J; Azzollini N; Aiello S; Abbate M; Trochimowicz L; Gagliardini E; Arduini A; Perico N; Remuzzi G
    Kidney Int; 2002 Mar; 61(3):1064-78. PubMed ID: 11849462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hydroxycobalamin[c-lactam] on propionate and carnitine metabolism in the rat.
    Brass EP; Allen RH; Ruff LJ; Stabler SP
    Biochem J; 1990 Mar; 266(3):809-15. PubMed ID: 2327967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carnitine therapy and metabolism in the disorders of propionyl-CoA metabolism studied using 1H-NMR spectroscopy.
    Davies SE; Iles RA; Stacey TE; de Sousa C; Chalmers RA
    Clin Chim Acta; 1991 Dec; 204(1-3):263-77. PubMed ID: 1819469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass isotopomer study of anaplerosis from propionate in the perfused rat heart.
    Kasumov T; Cendrowski AV; David F; Jobbins KA; Anderson VE; Brunengraber H
    Arch Biochem Biophys; 2007 Jul; 463(1):110-7. PubMed ID: 17418801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.
    Calvani M; Reda E; Arrigoni-Martelli E
    Basic Res Cardiol; 2000 Apr; 95(2):75-83. PubMed ID: 10826498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria.
    Ferrari R; Ceconi C; Cargnoni A; Pasini E; Boffa GM; Curello S; Visioli O
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():57-65. PubMed ID: 2031872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of propionyl-L-carnitine on cardiac dysfunction in streptozotocin-diabetic rats.
    Terada R; Matsubara T; Koh N; Nakamura J; Hotta N
    Eur J Pharmacol; 1998 Sep; 357(2-3):185-91. PubMed ID: 9797035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of isolated perfused working rat heart from oxidative stress by exogenous L-propionyl carnitine.
    Ronca G; Ronca F; Yu G; Zucchi R; Bertelli A
    Drugs Exp Clin Res; 1992; 18(11-12):475-80. PubMed ID: 1308473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of oxidative metabolism in volume-overloaded rat hearts: effect of pretreatment with propionyl-L-carnitine.
    Moravec J; El Alaoui-Talibi Z; Moravec M; Guendouz A
    Adv Exp Med Biol; 1996; 388():205-12. PubMed ID: 8798813
    [No Abstract]   [Full Text] [Related]  

  • 39. Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria.
    Sayed-Ahmed MM; Shouman SA; Rezk BM; Khalifa MH; Osman AM; El-Merzabani MM
    Pharmacol Res; 2000 Feb; 41(2):143-50. PubMed ID: 10623482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propionyl-L-carnitine: a new compound in the metabolic approach to the treatment of effort angina.
    Lagioia R; Scrutinio D; Mangini SG; Ricci A; Mastropasqua F; Valentini G; Ramunni G; Totaro Fila G; Rizzon P
    Int J Cardiol; 1992 Feb; 34(2):167-72. PubMed ID: 1737667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.